| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 357704 | Cyanomorpholinodoxorubicin | 0.00220234298765534 | 0.07774095 |
| NSC 643006 | Null | 0.00220234298765537 | 0.14626678 |
| NSC 728091 | 6-[(3-Hydroxy)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8,9-methy lenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline | 0.00220234298765537 | 0.23653303 |
| NSC 677945 | Quinoline-5,8-dione, 6-[(3-hydroxy-3-phenyl-2-propyl)amino]- | 0.00298819091754573 | 0.13636166 |
| NSC 691215 | Null | 0.00298819091754573 | 0.2117999 |
| NSC 619031 | Analog of CC-1065 | 0.00311751113090891 | 0.13126985 |
| NSC 721386 | 5-Fluoro-2'-deoxyuridyl 2-(1,4-naphthoquinonyl)methyl N-methyl-N-(4-chlorobutyl) phosphoramidate | 0.00311751113090891 | 0.17081566 |
| NSC 76919 | 2-Pyridinecarboxylic acid, 5-amino-6-(7-amino-1,2,3,4,5,8-hexahydro- 5,8-dioxo-2-quinolinyl)-4-(2-hydroxy- 3,4-dimethoxyphenyl)-3-methyl- | 0.00311751113090891 | 0.22293529 |
| NSC 271967 | Methanaminium, N-[4-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,2-benzenedicarboxylate (1:1) | 0.00314218974141796 | 0.055808205 |
| NSC 663790 | Null | 0.00314218974141796 | 0.09494194 |